Ximelagatran in orthopaedic surgery. - Wikidata - wikimedia - TriplyDB

Ximelagatran in orthopaedic surgery.

Ximelagatran in orthopaedic surgery.

http://www.wikidata.org/entity/Q36090077

about

Ximelagatran in orthopaedic surgery.

http://www.wikidata.org/entity/Q36090077

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Ximelagatran in orthopaedic surgery.

@ast

Ximelagatran in orthopaedic surgery.

@en

type

label

Ximelagatran in orthopaedic surgery.

@ast

Ximelagatran in orthopaedic surgery.

@en

prefLabel

Ximelagatran in orthopaedic surgery.

@ast

Ximelagatran in orthopaedic surgery.

@en

P1433

Q36090077-A6ECC28A-3D71-4C48-8608-9E281B925F29

P1476

Q36090077-BE77E9BC-AC43-4189-BCE5-0396A1153B96

P2093

Q36090077-45BD70A5-953C-4EFB-92B7-634EFF271051

P2860

Q36090077-022C3032-A7B1-4053-82E0-A0AFA2A8C4EB

Q36090077-10DDFD80-CB0D-42E5-B73F-88FB48279E45

Q36090077-168E27C7-521B-4CCA-A9A6-24996B4E9AEC

Q36090077-2CBE5D6E-5D3A-42F0-BDAA-197D0FDF27E1

Q36090077-3BE33390-CE94-4B95-81EA-11FDFDCE8F13

Q36090077-3FB09E00-376D-4E35-8001-DE4ECA0C8B82

Q36090077-412AC55A-58F4-4239-A0A7-9572C2573D5B

Q36090077-41C78660-62C6-43F4-B13C-862986D4F2FF

Q36090077-6082A657-B21A-44E0-9242-37BFBC9CAA84

Q36090077-7A0D6952-9018-4CEF-9A82-576488AAEB24

P304

Q36090077-F1321C27-4348-4738-A18E-9129AF571F7F

P31

Q36090077-15543B6C-4E2D-4988-8A8B-12FFC159A105

P356

Q36090077-97609481-0027-4BBB-BC94-BCFEBEDC5E07

P478

Q36090077-0009EA62-8D6D-4D97-9E2A-C65BF34E44DC

P577

Q36090077-99DE56DB-BC21-4C9D-9EDA-A04E1549F8F0

P698

Q36090077-EB27B050-5919-4768-956D-840E45FC5B7F

P356

P1433

Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research

P1476

Ximelagatran in orthopaedic surgery.

@en

P2093

Bengt Eriksson

http://www.w3.org/2001/XMLSchema#string

P2860

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

Current controversies in deep vein thrombosis prophylaxis after orthopaedic surgery.

The epidemiology of venous thromboembolism.

A novel approach to thrombin inhibition.

Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.

A new oral anticoagulant: the 50-year challenge.

STUDIES IN EXPERIMENTAL EXTRACORPOREAL THROMBOSIS : III. EFFECTS OF CERTAIN ANTICOAGULANTS (HEPARIN AND HIRUDIN) ON EXTRACORPOREAL THROMBOSIS AND ON THE MECHANISM OF THROMBUS FORMATION.

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.

P304

10-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000083079

http://www.w3.org/2001/XMLSchema#string

P478

34 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15812199

http://www.w3.org/2001/XMLSchema#string